Risk Factors and Mode of Death in Isolated Hypertrophic Cardiomyopathy in Children

Journal of the American College of Cardiology

Volumn 54, Issue 3, 2009, Pages 250-254

  Decker, Jamie A ^a   Rossano, Joseph W ^a   Smith, E O'Brian ^a   Cannon, Bryan ^a   Clunie, Sarah K ^a   Gates, Corey ^a   Jefferies, John L ^a   Kim, Jeffrey J ^a   Price, Jack F ^a   Dreyer, William J ^a   Towbin, Jeffrey A ^a   Denfield, Susan W ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

cardiomyopathy; hypertrophy; implantable cardioverter defibrillator; pediatrics; sudden cardiac death; ventricular tachycardia

Indexed keywords

ADULT; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR RISK; CHILD; ECHOCARDIOGRAPHY; EXERCISE; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE HYPERTROPHY; HEART TRANSPLANTATION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SCHOOL CHILD; SUDDEN DEATH;

ADOLESCENT; AGE FACTORS; ALGORITHMS; CARDIOMYOPATHY, HYPERTROPHIC; CHILD; COHORT STUDIES; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; DISEASE PROGRESSION; EXERCISE; FEMALE; HEART FAILURE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; HYPOTENSION; KAPLAN-MEIERS ESTIMATE; MALE; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; TEXAS;

EID: 67649589472     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2009.03.051     Document Type: Article

References (9)

1. Ostman-Smith I., Wettrell G., and Riesenfeld T. A cohort study of childhood hypertrophic cardiomyopathy: improved survival following high-dose beta-adrenoceptor antagonist treatment. J Am Coll Cardiol 34 (1999) 1813-1822
2. Colan S.D., Lipshultz S.E., Lowe A.M., et al. Epidemiology and cause-specific outcome of hypertrophic cardiomyopathy in children: findings from the Pediatric Cardiomyopathy Registry. Circulation 115 (2007) 773-781
3. Nugent A.W., Daubeney P.E., Chondros P., et al. Clinical features and outcomes of childhood hypertrophic cardiomyopathy: results from a national population-based study. Circulation 112 (2005) 1332-1338
4. Maron B.J., McKenna W.J., Danielson G.K., et al. ACC/ESC clinical expert consensus document on hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines (Committee to Develop an Expert Consensus Document on Hypertrophic Cardiomyopathy). J Am Coll Cardiol 42 (2003) 1687-1713
5. Monserrat L., Elliott P.M., Gimeno J.R., Sharma S., Penas-Lado M., and McKenna W.J. Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy: an independent marker of sudden death risk in young patients. J Am Coll Cardiol 42 (2003) 873-879
6. Dimitrow P.P., and Dubiel J.S. Echocardiographic risk factors predisposing to sudden cardiac death in hypertrophic cardiomyopathy. Heart 91 (2005) 93-94
7. McMahon C.J., Nagueh S.F., Pignatelli R.H., et al. Characterization of left ventricular diastolic function by tissue Doppler imaging and clinical status in children with hypertrophic cardiomyopathy. Circulation 109 (2004) 1756-1762
8. Ostman-Smith I., Wettrell G., Keeton B., Riesenfeld T., Holmgren D., and Ergander U. Echocardiographic and electrocardiographic identification of those children with hypertrophic cardiomyopathy who should be considered at high-risk of dying suddenly. Cardiol Young 15 (2005) 632-642
9. Harris K.M., Spirito P., Maron M.S., et al. Prevalence, clinical profile, and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy. Circulation 114 (2006) 216-225